SEC Form 4 · accession 0000950138-17-000152
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven J. Romano
Officer — Exec. VP & Chief Sci. Ofcr
Period of report
Feb 10, 2017
Accepted (ET)
Feb 13, 2017 · 8:46 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Feb 10, 2017 | P | 1,000 | $49.68 | A | 21,023 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 180 shares acquired on December 31, 2016 under the Mallinckrodt employee stock purchase plan.